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ABSTRACT:
Introduction: High prevalence rate of thyroid dysfunction associated infertility is identified by a number of studies 
in Nepal. Thyroid dysfunction not only affects fertility but is also associated with miscarriage and fetal death. The 
objective of this study was to measure the fertility rate after low dose Thyroxine, 12.5 microgram, in women with 
subfertility. Methods: This was a descriptive and observational study done among women visiting infertility and 
in-vitro fertilization (IVF) center at Nepalgunj Medical College, Nepal. After undergoing baseline investigations for 
infertility, all women diagnosed with primary or secondary infertility were enrolled in the study. Male factor and tubal 
factor infertility was excluded. All 136 women who were enrolled in the study received 12.5 microgram of thyroxine 
supplementation for a period of three months and subsequently followed up until the same time period. Results: 
Out of 136 women, 83 (61.02%) women achieved pregnancy within three months of supplementation with low 
dose thyroxine. Among them, 34 (40.9%) women with primary infertility achieved pregnancy within three months. 
Similarly 14 (16.8%) women with previous miscarriage, 20 (24.09%) women with previous caesarean section within 
past five years back, and 15 (18.07%) with previous IUFD achieved pregnancy within three months. Conclusion: 
Low dose thyroxine supplementation would be beneficial and recommended to subfertile women of reproductive age 
group in the endemic regions of hypothyroidism. Dose adjustment would give extended benefits as soon as pregnancy 
is achieved.
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Thyroid hormones are necessary to have 
a healthy reproductive system in women of 
reproductive age group. Female sex hormones 
and functioning of reproductive system are 
frequently altered due to hypothyroidism or 
hyperthyroidism which manifests as menstrual 
disorders like hypomenorrhoea, polymenorrhoea, 
and oligomenorrhoea.1 Hypothyroidism is one of the 
common public health problems in Nepal due to the 
location of this country which is far from the sea. Food 
products available here area poor source of iodine 
and iron. Nutritional subclinical hypothyroidism and 
iron deficiency anemia are highly prevalent in this 
region and about 40-50% women and children have 
mild grade anemia. Thyroid hormone is necessary 
for better iron absorption.2 About 5-6% of women 
population have hypothyroidism and related illness. 
There is a strong relationship between thyroid 
immunity and infertility, miscarriages, and fetal 
death. Approximately 8-12% of all pregnancy 
losses are due to endocrine factors.3 Subclinical 
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hypothyroidism is more prevalent than overt 
hypothyroidism. Approximately 80% of patients 
with subclinical hypothyroidism have thyroid 
stimulating hormone ≤10 mlU/L. About 11.8% 
infertile women have subclinical hypothyroidism.4 
Secondary amenorrhea due to neuroendocrine cause 
is approximately 6-10% in reproductive age group 
women. Among them, 3-4% have got infertility.5 A 
high incidence of hyperprolactinaemia was found in 
infertile women and a positive correlation was found 
between hyperprolactinemia and hypothyroidism.6 
It is a fact that thyroid hormone deficiency is more 
common in women with polycystic ovary syndrome.7 
Subclinical hypothyroidism has a significant 
association with intrauterine growth restriction as 
well as low APGAR score at first minute.8 Although 
current evidence does not support that treatment of 
non-overt thyroid disorders improves maternal and 
fetal outcomes, further research has been suggested 
in some studies.9
On one hand, levothyroxine treatment is cost-
saving and it improves the subsequent pregnancy rate 
in women with spontaneous abortions. On the other 
hand, only a few studies show that levothyroxine 
substitution is able to lower the chance of miscarriage 
and premature delivery.10,11 With this background, 
this study intends to measure the fertility benefits of 
low dose thyroxine supplementation in cases of sub-
fertility.
METHODS:
This was a descriptive, observational study 
comprising a total of 136 cases of primary and 
secondary sub-fertility visiting infertility and in-
vitro fertilization (IVF) center of Nepalgunj Medical 
College, Nepalgunj. The cases were enrolled over a 
period of one year (July 2015 to June 2016). The 
inclusion criteria for the selection of cases were 
women who were unable to conceive after more 
than one year of regular sexual intercourse and 
diagnosed as cases of sub-fertility. Those who 
conceived but were unable to sustain pregnancy until 
term including the history of previous miscarriage, 
previous intrauterine fetal deaths, and previous 
operative delivery and unable to conceive for five 
years of first operative birth were included in the 
study as cases as sub-fertility.
Cases with male factor and tubal factors 
infertility with any congenital anomaly of urogenital 
tract, or any obvious organic pathology were 
excluded. Those women who had history of thyroid 
disease, thyroid surgery in the past and those treated 
with thyroid or anti-thyroid medications were also 
excluded.
Ethical approval and clearance were taken 
from ethical review committee of Nepalgunj Medical 
College Teaching Hospital. Informed consent was 
taken from all women. Detailed history and personal 
contact numbers was recorded. Investigations 
including complete blood count, serology, thyroid 
stimulating hormone (TSH) test, serum prolactin, 
hysterosalpingogram, urine routine examination and 
urine for β-HCG test were done. All women received 
tablet thyroxine 12.5 microgram per day in an empty 
stomach.
The base line TSH profile was categorized as: 
euthyroid: TSH 0.46 - 4.5 mIU/ml; hypothyroidism: 
TSH > 4.5 mIU/ml; hyperthyroidism: TSH< 0.46 
mIU/ml.12,13,14 Dose adjustment was done as soon 
as the reports of thyroid functions were received. 
Thyroxin 12.5 microgram was continued to those 
who were euthyroid, thyroxine 25 microgram was 
given for subclinical hypothyroidism and thyroxin 
50 microgram for primary hypothyroidism. 
Antithyroxin was prescribed to those who had 
hyperthyroidism. All women were followed up 
for three months and pregnancy rate measured. 
Microsoft Office Excel 2007 tool was used for 
statistical analysis.
RESULTS:
There were 5670 women attending 
Gynecology outpatient department, Nepalgunj 
Medical College during the study period. Out of 
these, 326 were women with sub-fertility giving 
a hospital incidence of 5.7%. Out of these, 136 
women were diagnosed with sub-fertility after 
basic investigations excluding tubal and male 
factor infertility. Seventy two women (53%) had 
primary infertility; 26 (19%) had history of previous 
caesarean section unable to conceive for more than 
one year of regular sexual intercourse; 21(15%) had 
previous miscarriages and 17 (13%) had previous 
history of intra-uterine fetal death (IUFD). 
Mean age of the study subjects were 26.3 yr 
(SD=3.5). Among 136 women, 98 (72.05%) were 
euthyroid, 37 (27.2%) had hypothyroidism, and one 
(0.7%) had hyperthyroidism. 
Eighty-three (61.02%) women achieved 
pregnancy within three months of supplementation 
with low dose thyroxine and folic acid. Among 
them, 34 (40.9%) women with primary infertility, 
14 (16.8%) women with previous miscarriage, 20 
(24.09%) women with previous CS within past five 
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years, and 15 (18.07%) women with previous IUFD 
achieved pregnancy within three months.
DISCUSSION:
 This study revealed that 27.9% of study 
population had thyroid dysfunction associated with 
infertility. Majority of thyroid dysfunction was 
hypothyroidism (27.2%); subclinical hypothyroidism 
being the most common (19.5%). Similarly, 
subclinical hypothyroidism was found to be one of 
the important thyroid dysfunction associated with 
infertility in previous studies.4,15 The overall fertility 
rate was 61.02% achieved by low dose thyroxine. 
Significant achievement was observed in fertility 
rate ranging from 76.9% to 88.2% in secondary 
sub-fertility including previous operative delivery, 
previous history of miscarriage, and history of IUFD.
 Subclinical hypothyroidism may be 
associated with ovulatory dysfunction and adverse 
pregnancy outcome. The high prevalence of 
hypothyroidism in infertile women shown in this 
study is also comparable with other similar studies.4,16 
Higher prevalence of hypothyroidism in our 
population is due to iodine insufficiency in the diet.17 
About 13.6% of population have iodine deficiency 
in Nepal and the prevalence of hypothyroidism is 
more in pregnant than in non-pregnant women.18,19 
Autoimmune thyroiditis  may also be contributed 
to high prevalence rate of hypothyroidism in our 
population. The diagnosis of which is beyond the 
scope of this study.
 Clinical or subclinical hypothyroidism 
can cause oligomenorrhea and amenorrhea, 
polymenorrhea, and menorrhagia in reproductive 
age group women. High rate of infertility in 
hypothyroidism alter peripheral estrogen metabolism. 
It is also associated with hyperprolactinemia which 
ultimately disturbs the release of gonadotrophin 
releasing hormone (GnRH) secretion and luteinizing 
hormone (LH) surge.20,21
 Thyroxine is necessary to achieve maximum 
fertilization rates and have special roles in oocyte 
physiology. Serum TSH levels is one of the 
significant predictors of fertilization failure in 
women undergoing IVF.22 Thyroxine normalizes 
prolactin levels as well as  LH responses to luteinizing 
hormone releasing hormone (LHRH), normalizes 
menstrual disturbances, and ultimately enhances the 
chances of spontaneous conception.23 So, it is very 
important to identify hypothyroidism in infertility.
 Low dose thyroxine supplementation is 
cost effective in those geographical areas where 
hypothyroidism is endemic. It may be useful even 
in women without overt hypothyroidism who need 
extra hormone to regularize their periods as well as 
to promote the follicular development. It also helps 
to maintain pregnancy.
CONCLUSION:
 Extended fertility rate was achieved in sub-
fertile women with regular low dose thyroxine 
supplementation for three months. Low dose 
thyroxine supplementation is recommended to 
sub-fertile women of reproductive age group in 
the endemic regions of hypothyroidism like Nepal. 
Dose adjustment according to lab test would give 
extended benefits as soon as pregnancy is achieved.
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